Oxford Expression Technologies Launches VLP Vaccine Production Services
Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, now applies its expertise to the production of recombinant vaccines, particularly in the field of virus like particle (VLP) vaccines.
View full press release